Literature DB >> 8864792

Tc-99m tetrofosmin myocardial distribution 4 hours post injection.

M Pillay1, P H Cox, D H Schönfeld, S Mathews.   

Abstract

The recommended protocol for Tc99m tetrofosmin myocardial imaging suggests either a one- or two day imaging protocol so that stress and rest studies are sufficiently separated in time to allow optimum myocardium to background uptake ratios to differentiate between myocardial ischaemia and/or infarction. The biokinetic data for tetrofosmin suggest that no significant changes occur in myocardial distribution up to 180 minutes post injection. It is, therefore, necessary for two doses of the radiopharmaceutical and two separate studies to evaluate the myocardial status during stress and rest. This study assessed the differences between the 1 and 4 hour post injection SPET images obtained following peak exercise in 20 consecutively chosen patients. In addition, these images were compared to the rest images obtained on the following day after a second dose of the radiopharmaceutical was administered. In 4 patients, a one and four hour post injection study was also done during the rest phase. The results demonstrate significant changes in Tc-99m tetrofosmin distribution between the one hour and four hour post injection images. These differences are present during the stress as well as rest studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864792     DOI: 10.1007/bf01880744

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  11 in total

1.  Myocardial single-photon emission computed tomographic imaging with technetium 99m tetrofosmin: stress-rest imaging with same-day and separate-day rest imaging.

Authors:  B Sridhara; H Sochor; P Rigo; S Braat; R Itti; D Martinez-Duncker; P Cload; A Lahiri
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

2.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

Authors:  D Jain; F J Wackers; J Mattera; M McMahon; A J Sinusas; B L Zaret
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

3.  Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.

Authors:  B S Sridhara; S Braat; P Rigo; R Itti; P Cload; A Lahiri
Journal:  Am J Cardiol       Date:  1993-11-01       Impact factor: 2.778

4.  Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin.

Authors:  K Nakajima; J Taki; N Shuke; H Bunko; S Takata; K Hisada
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

5.  Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography.

Authors:  P Rigo; B Leclercq; R Itti; A Lahiri; S Braat
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

6.  Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.

Authors:  N Tamaki; N Takahashi; M Kawamoto; T Torizuka; E Tadamura; Y Yonekura; K Okuda; R Nohara; S Sasayama; J Konishi
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

7.  Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.

Authors:  A J Sinusas; Q Shi; M T Saltzberg; P Vitols; D Jain; F J Wackers; B L Zaret
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

8.  Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols.

Authors:  S H Braat; B Leclercq; R Itti; A Lahiri; B Sridhara; P Rigo
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

9.  Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.

Authors:  J D Kelly; A M Forster; B Higley; C M Archer; F S Booker; L R Canning; K W Chiu; B Edwards; H K Gill; M McPartlin
Journal:  J Nucl Med       Date:  1993-02       Impact factor: 10.057

10.  Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images.

Authors:  R Taillefer; M Primeau; P Costi; R Lambert; J Léveillé; Y Latour
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

View more
  2 in total

1.  Influence of respiratory motion correction on quantification of myocardial perfusion SPECT.

Authors:  Ahmad Bitarafan-Rajabi; Hossein Rajabi; Feridoon Rastgou; Hasan Firoozabady; Nahid Yaghoobi; Hadi Malek; Werner Langesteger; Mohsen Beheshti
Journal:  J Nucl Cardiol       Date:  2014-12-17       Impact factor: 5.952

2.  Respiratory motion detection and correction in ECG-gated SPECT: a new approach.

Authors:  Ahmad Bitarafan; Hossein Rajabi; Bernhard Gruy; Feridoon Rustgou; Ali Akbar Sharafi; Hasan Firoozabady; Nahid Yaghoobi; Hadi Malek; Christian Pirich; Werner Langesteger; Mohsen Beheshti
Journal:  Korean J Radiol       Date:  2008 Nov-Dec       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.